- Report
- July 2018
- 11 Pages
Global
From €9655EUR$10,000USD£8,176GBP
- Report
- July 2018
- 18 Pages
Global
From €9655EUR$10,000USD£8,176GBP
- Report
- July 2018
- 19 Pages
Global
From €9655EUR$10,000USD£8,176GBP
- Report
- June 2024
- 50 Pages
Global
From €2559EUR$2,650USD£2,167GBP
- Report
- December 2022
- 210 Pages
Global
From €3563EUR$3,690USD£3,017GBP
- Report
- March 2023
- 147 Pages
Global
From €5792EUR$5,999USD£4,905GBP
Tiotropium is a long-acting anticholinergic drug used to treat chronic obstructive pulmonary disease (COPD). It is a bronchodilator, meaning it relaxes the muscles in the airways, allowing more air to flow in and out of the lungs. It is available in both an inhaler and a dry powder inhaler. Tiotropium is the only long-acting anticholinergic approved for the treatment of COPD. It is also used to treat asthma and other respiratory conditions.
Tiotropium is a popular drug in the respiratory drugs market, as it is effective in treating COPD and other respiratory conditions. It is also well-tolerated, with few side effects. It is available in both generic and brand-name forms, making it accessible to a wide range of patients.
Some companies in the Tiotropium market include Boehringer Ingelheim, GlaxoSmithKline, and Novartis. Show Less Read more